Drug market research firm in Thailand
Managing Thailand’s Pharmaceutical Environment: Your Research Partner
Thailand’s pharmaceutical market is characterized by a mix of local manufacturers, multinational players, and a growing demand for specialized treatments.
The country serves as a hub for medical tourism, influencing the types of drug innovations and healthcare services sought by consumers. Understanding patient pathways and physician prescribing habits requires granular, in-country intelligence. To discuss your specific project needs, share your brief with our team.
Global Vox Populi acts as your experienced partner, providing actionable insights for the Thai healthcare sector.
What we research in Thailand
We scope drug market research projects in Thailand to address specific client objectives. Our work includes brand health tracking for pharmaceutical products and comprehensive treatment journey mapping for various diseases.
We also conduct market access and pricing studies for new drug formulations entering the Thai market. We analyze physician and pharmacist segmentation, alongside patient adherence and experience studies.
Additionally, we support message testing for healthcare professionals (HCPs) and consumers, opportunity sizing for therapeutic areas, and competitive intelligence on new drug launches. We also regularly integrate quantitative methods like quantitative research in Thailand to provide a holistic view of the market.
Why Drug market research fits (or struggles) in Thailand
Drug market research in Thailand benefits from a reliable healthcare infrastructure in major urban centers and increasing digital literacy among HCPs. This digital adoption supports efficient online surveys and in-depth interviews.
There is also a growing middle class with higher healthcare spending and a general willingness among medical professionals to participate for educational incentives. This makes reaching key opinion leaders and specialists feasible.
However, challenges exist. Reaching HCPs or patients in rural areas can be complex due to connectivity and geographic spread. Cultural nuances around discussing health conditions, particularly sensitive ones, require experienced and empathetic moderation.
While Thailand’s PDPA addresses data privacy, careful consent processes are always essential. Recruitment for rare disease patient groups remains a global challenge. For highly nuanced topics or deep dives, we frequently recommend complementing this with in-depth interviews.
How we run Drug market research in Thailand
Our drug market research projects in Thailand employ a mix of specialized methodologies.
For recruitment, we use verified in-country B2B panels focusing on healthcare professionals (HCPs) and ethically approved patient advocacy groups. We sometimes conduct hospital or clinic intercepts for specific patient cohorts, where appropriate. We do not rely on river sampling for these specialized audiences.
Our screening process is rigorous. It includes specialty verification for HCPs, assessment of prescribing habits, patient load, and recent participation flags. We incorporate medical validators to confirm professional status and attention checks within surveys to maintain data integrity.
Fieldwork is often conducted via online in-depth interviews (IDIs) using platforms like Zoom or Teams for HCPs, or in-person IDIs and focus group discussions in central locations for patients or specialists. Broader reach is achieved through online surveys.
The primary language for our research is Thai. We also cover English for international participants or specific expat HCP communities in Thailand. Our moderators and interviewers are native Thai speakers with backgrounds in healthcare, pharmacy, or social sciences.
They receive specific training on pharmaceutical research ethics, medical terminology, and cultural sensitivities. Quality assurance during fieldwork includes live monitoring of IDIs, back-checks on a percentage of completed surveys, and cross-referencing qualitative data with screening responses.
We maintain regular check-ins with our fieldwork partners. Deliverables typically include detailed transcripts (Thai and English translation), summary reports, debrief decks, and raw data files or dashboard access.
A single project lead manages your study from kickoff to final debrief, providing consistent updates on fieldwork progress and initial findings.
Where we field in Thailand
Our fieldwork capabilities for drug market research extend across Thailand. We have strong operational presence in major urban centers such as Bangkok, Chiang Mai, Phuket, and Pattaya.
These cities concentrate a significant number of hospitals, clinics, and pharmaceutical professionals, making them key areas for our research. We also reach beyond these dominant hubs into regional and some rural areas, particularly for patient research.
This is achieved through our network of local partners and mobile interview teams. While Thai is the primary language of research, we conduct studies in English for specific international or expat HCP segments.
Our network allows for research across all major regions, guaranteeing representative samples whether the target is general practitioners or highly specialized surgeons. Our expertise extends to similar markets, and we also conduct drug market research in Malaysia, using regional insights.
Methodology, standards, and ethics
We conduct drug market research in Thailand adhering to global and local ethical guidelines.
This includes ESOMAR, the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision), and where applicable, ISO 20252:2019. For Thailand, we align with the Marketing Research Society of Thailand (MRST) guidelines.
Our methodology for drug research often incorporates semi-structured guides for in-depth interviews, delivering consistent probing while allowing for emergent themes. For quantitative studies, we follow AAPOR response rate definitions to report on data quality.
Applying these standards means explicit consent capture for all participants, clearly outlining research objectives and data usage. For drug research, this involves specific consent for discussing sensitive health information and delivering anonymity for both HCPs and patients.
We provide clear disclosures regarding the sponsor’s industry, without revealing their identity unless required and consented to. All research involving patients or sensitive medical data undergoes an ethical review process to safeguard participant welfare.
Quality assurance measures are built into every stage of the project lifecycle. This includes peer review of research instruments, such as questionnaires and discussion guides, before fieldwork commences.
We conduct back-checks on a percentage of completed interviews for validation and rigorous quota validation for quantitative samples. For qualitative data, transcripts are reviewed for accuracy, and coding is cross-checked by a second analyst.
Statistical validation is applied to quantitative datasets to deliver data integrity and reliability before analysis.
Drivers and barriers for Drug market research in Thailand
DRIVERS:
- Growing Healthcare Expenditure: Thailand’s increasing healthcare budget and its role as a medical tourism destination drive demand for pharmaceutical innovation and market understanding.
- Digital Adoption: Higher digital literacy among Thai HCPs, particularly in urban areas, supports online research methods, improving reach and efficiency.
- Aging Population: The demographic shift towards an older population creates demand for new drugs and treatments, prompting more research into chronic diseases and geriatric care solutions.
- Government Support: Initiatives to promote Thailand as a medical hub encourage investment in healthcare, including pharmaceutical development and related research activities.
- Willingness to Participate: Many Thai medical professionals are open to participating in research, valuing the opportunity to share insights and contribute to medical advancement and knowledge.
BARRIERS:
- Cultural Sensitivity: Discussions around certain diseases or health conditions require careful phrasing and empathetic moderation to avoid discomfort or underreporting from participants.
- Data Access for Rare Conditions: Identifying and recruiting patients for rare diseases can be challenging, often requiring collaboration with patient advocacy groups or specialized clinics.
- Geographic Dispersion: Reaching HCPs and patients in remote or rural areas can be logistically complex and more time-consuming than conducting research in urban centers.
- Panel Fatigue: Over-surveying of specific medical specialties can lead to panel fatigue, necessitating diverse recruitment strategies and a broad network of fieldwork partners.
- Regulatory Nuances: Managing specific regulations related to pharmaceutical marketing and research in Thailand requires expert knowledge to deliver full compliance.
Compliance and data handling under Thailand’s framework
Thailand operates under the Personal Data Protection Act (PDPA), 2019. This law governs the collection, use, and disclosure of personal data, aligning with international standards.
For drug market research, we make sure explicit consent is obtained from all participants, especially for sensitive health information. Data residency requirements are met by processing and storing data within compliant frameworks, or through reliable anonymization practices if international transfer is necessary.
Participants retain the right to withdraw consent and request data erasure, and our processes fully support these rights. We prioritize data minimization, collecting only data essential for research objectives and adhering to defined retention policies.
Top 20 industries we serve in Thailand
- Pharma & Biotech: HCP segmentation, treatment journey mapping, market access studies for new drugs.
- Healthcare Providers: Patient experience research, hospital choice drivers, service perception studies.
- Medical Devices: Product concept testing, physician adoption barriers, post-market surveillance research.
- FMCG & CPG: Pack testing for health-related products, U&A studies, shopper journey research in pharmacies.
- Banking & Financial Services: Customer experience tracking for health insurance products, digital banking usage.
- Insurance: Claims experience research, policyholder satisfaction, health insurance product development.
- Retail & E-commerce: Online pharmacy experience, health product purchasing behavior, store format research.
- Technology & SaaS: Digital health app usability, telemedicine adoption, health tech product-market fit.
- Telecom: Mobile health service usage, connectivity for remote patient monitoring.
- Food & Beverage: Health and wellness trends, functional food ingredient testing, dietary supplement market.
- Beauty & Personal Care: Dermocosmetic efficacy claims, consumer perception of natural ingredients, anti-aging research.
- Automotive & Mobility: Impact of health conditions on driving behavior, accessibility for patients.
- Travel & Hospitality: Medical tourism motivations, patient travel experience, wellness retreat demand.
- Education: Medical student career paths, professional development for HCPs, health education program effectiveness.
- Government & Public Sector: Public health campaign effectiveness, citizen satisfaction with healthcare services.
- NGO & Development: Health program evaluation, community health needs assessment, disease prevention research.
- Real Estate: Healthcare facility location preferences, senior living community demand.
- Logistics & Supply Chain: Pharmaceutical cold chain logistics, medical supply distribution efficiency.
- Agriculture: Veterinary pharmaceutical research, animal health product market access.
- Chemicals: Raw material sourcing for pharmaceutical manufacturing, regulatory compliance research.
Companies and brands in our research universe in Thailand
Research projects we field in Thailand regularly cover the competitive sets of category leaders such as:
- Siam Bioscience
- GSK Thailand
- Sanofi Thailand
- Pfizer Thailand
- AstraZeneca Thailand
- Novartis Thailand
- Merck Sharp & Dohme (MSD) Thailand
- Takeda Thailand
- Bayer Thailand
- Boehringer Ingelheim Thailand
- Bangkok Dusit Medical Services (BDMS)
- Bumrungrad International Hospital
- Watsons Thailand
- Boots Retail (Thailand)
- CP Group (healthcare investments)
- True Corporation (digital health initiatives)
- Siam Cement Group (SCG) (healthcare sector)
- Minor International (wellness tourism)
- Dole Thailand (health food)
- Blackmores (supplements)
Why teams choose Global Vox Populi as their Drug market research firm in Thailand
Translation and back-translation for medical documents and interviews are handled in-house by native Thai and English speakers with healthcare industry knowledge.
- A single project lead from kickoff through debrief delivers consistent communication and deep understanding of your project objectives.
- We offer advanced sampling techniques specifically designed to reach low-incidence HCPs and patient groups within Thailand’s healthcare network.
Frequently Asked Questions
Q: What kinds of clients commission drug market research in Thailand?
A: We work with pharmaceutical manufacturers, biotech companies, medical device firms, and healthcare providers. We also work with government health agencies, NGOs, and consultants requiring insights into the Thai healthcare market. These organizations seek data on market access, treatment pathways, product development, and competitive intelligence to inform their strategies.
Q: How do you deliver sample quality for Thailand’s diverse population?
A: We employ rigorous screening questionnaires and verification processes to deliver sample quality. For HCPs, this involves professional license checks and specialty validation. For patients, we work with ethical patient advocacy groups and use strict inclusion/exclusion criteria. Our in-country partners have established panels and recruitment methods that account for urban-rural splits and regional demographics.
Q: Which languages do you cover in Thailand?
A: Our primary research language in Thailand is Thai, handled by native-speaking moderators and interviewers. We also conduct research in English for specific audiences, such as expat healthcare professionals or international stakeholders. All translations and back-translations of research materials and outputs are performed by medically trained linguists.
Q: How do you reach hard-to-find audiences (senior B2B, low-incidence consumer segments) in Thailand?
A: Reaching these audiences often requires specialized approaches. We use targeted B2B panels, professional associations, and sometimes direct outreach through key opinion leaders for senior B2B groups. For low-incidence patient segments, we work with patient support groups and specialized clinics, making sure all recruitment is ethically compliant and respects privacy regulations.
Q: What is your approach to data privacy compliance under Thailand’s framework?
A: We operate under Thailand’s Personal Data Protection Act (PDPA), 2019. Our approach includes explicit, informed consent for all participants, especially concerning sensitive health data. We implement data minimization, anonymization, and secure storage protocols. Participants are informed of their rights, including data access, correction, and withdrawal of consent, which we fully support.
Q: Can you combine drug market research with other methods (IDIs + online surveys, etc.)?
A: Yes, we frequently design hybrid methodologies. For instance, we might use qualitative in-depth interviews (IDIs) to deeply explore physician perceptions, followed by a quantitative online survey to validate findings across a broader HCP sample. This mixed-method approach provides both depth of understanding and statistical generalizability for drug market insights.
Q: How do you manage cultural sensitivity in Thailand?
A: Cultural sensitivity is essential in Thai healthcare research. Our local moderators and researchers are trained in specific cultural nuances, making sure questions are framed respectfully and discussions proceed appropriately. We avoid direct questioning on sensitive topics, preferring indirect or projective techniques where necessary. All materials are culturally reviewed before fieldwork.
Q: Do you handle both HCP and patient research in Thailand?
A: Yes, we have extensive experience conducting both healthcare professional (HCP) and patient research in Thailand. Our network includes panels and recruitment channels for various medical specialties and patient populations. This dual capability allows us to provide a holistic view of the drug market, covering both prescribing behaviors and patient experiences.
Q: What deliverables do clients receive at the end of a drug market research project in Thailand?
A: Deliverables vary by project scope but typically include detailed research reports with key findings and strategic recommendations. Clients also receive comprehensive debrief presentations, often accompanied by raw data files, transcripts, and video excerpts from qualitative sessions. We can also provide interactive dashboards for quantitative data visualization.
This includes validation calls for a percentage of completed interviews, real-time monitoring of qualitative sessions, and logical checks within survey data. We conduct back-checks to verify participant eligibility and data accuracy.
Our project leads oversee fieldwork closely, delivering adherence to research protocols and data integrity.
When your next research brief involves Thailand, let’s talk through it. Request A Quote or View Case Studies from our work.